Heterodimeric antibodies to CD3 X CD123

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856327
APP PUB NO 20170081424A1
SERIAL NO

15186167

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel heterodimeric antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XENCOR INC111 WEST LEMON AVENUE MONROVIA CA 91016

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernett, Matthew J Monrovia, US 78 1622
Chu, Seung Cypress, US 30 659
Desjarlais, John Pasadena, US 132 2455
Lee, Sung-Hyung San Gabriel, US 23 200
Moore, Gregory Azusa, US 102 1835
Muchhal, Umesh Monrovia, US 29 361
Rashid, Rumana Temple City, US 67 1301

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00